Walleye Trading LLC Assembly Biosciences, Inc. Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.13 - $3.46 $37,607 - $61,089	-17,656 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.14 - $3.9 $55,439 - $68,858	17,656 New	17,656 $61,000
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $126,410 - $151,692	-33,266 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $41,715 - $63,873	-9,634 Reduced 22.46%	33,266 $153,000
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $208,923 - $741,741	42,900 New	42,900 $260,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.